Clinical Trial Update: Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) [Phase 3]

View source ↗

Summary

This update reports the Phase 3 EXPAND trial evaluating maralixibat for pruritus in general cholestatic liver disease, noting the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestatic Liver Disease

Drugs mentioned

• Maralixibat (maralixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) | Phase 3 | Status: ACTIVE_NOT_RECRUITING